Lotus seed oligosaccharides at various dosages with prebiotic activity regulate gut microbiota and relieve constipation in mice. by Su, Han et al.
Journal Pre-proof
Lotus seed oligosaccharides at various dosages with prebiotic activity regulate gut
microbiota and relieve constipation in mice
Han Su, Jinghao Chen, Song Miao, Kaibo Deng, Jiawen Liu, Shaoxiao Zeng,




To appear in: Food and Chemical Toxicology
Received Date: 21 August 2019
Revised Date: 18 September 2019
Accepted Date: 24 September 2019
Please cite this article as: Su, H., Chen, J., Miao, S., Deng, K., Liu, J., Zeng, S., Zheng, B., Lu, X.,
Lotus seed oligosaccharides at various dosages with prebiotic activity regulate gut microbiota and
relieve constipation in mice, Food and Chemical Toxicology (2019), doi: https://doi.org/10.1016/
j.fct.2019.110838.
This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition
of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of
record. This version will undergo additional copyediting, typesetting and review before it is published
in its final form, but we are providing this version to give early visibility of the article. Please note that,
during the production process, errors may be discovered which could affect the content, and all legal
disclaimers that apply to the journal pertain.
© 2019 Published by Elsevier Ltd.
 
 
Lotus seed oligosaccharides at various dosages with prebiotic activity 
regulate gut microbiota and relieve constipation in mice 
Running title: Oligosaccharides improve microbiota and constipation 
Han Sua,d,e, Jinghao Chena,d,e, Song Miaob,a,d, Kaibo Denga,b,c,d,e, Jiawen Liua, 
Shaoxiao Zenga,c,d,e*, Baodong Zhenga,c,d,e, Xu Lua,b,c,d,e*1 
a College of Food Science, Fujian Agriculture and Forestry University, 15 Shangxiadian Road, 
350002 Fuzhou, China 
b Teagasc Food Research Centre, Food Chemistry and Technology Department, Moorepark, 
Fermoy, Co.Cork, Ireland  
c Institute of Food Science and Technology, Fujian Agriculture and Forestry University, 18 Simon 
Pit Road, 350002 Fuzhou, China 
d China-Ireland International Cooperation Center for Food Material Science and Structure Design, 
Fujian Agriculture and Forestry University, 350002 Fuzhou, China; 
e Fujian Provincial Key Laboratory of Quality Science and Processing Technology in Special 




                                                             
*Corresponding Author at: College of Food Science, Fujian Agriculture and Forestry University, 
Fuzhou, 350002, China. Tel.: +86 59183736738; fax: +86 591 83739118 




Abstract: The aim of this study was to evaluate the effects of lotus seed 
oligosaccharides (formulation consisting of LSO2, LSO3-1, LSO3-2 and LSO4; 
relative ratios are 1.107:0.554: 0.183:0.443, m/m/m/m) at dosages of 0.42, 0.83 
g/d/kg bw and 2.49 g/d/kg bw on the microbiota composition and the propulsion of 
intestinal contents in the gut of mice. The results showed that fecal water content 
increased in treated mice; there was less gut microbiota diversity than in other 
groups; and there was a large number of fauna in the cecum of the mice. At the 
same time, the number of short-chain fatty acid (SCFA) bacterial producers 
increased after feeding with oligosaccharides; Lotus seed oligosaccharides (LOS) 
also enhanced the concentration of SCFAs in the intestine, which also increased the 
concentration of cytokines in the serum of mice. In conclusion, these findings 
suggest that LOS or combination with resistant starch has a better effect on 
relieving constipation. 
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Feeding with oligosaccharide-resistant starch complexes has a better effect on 
beneficial gut microbiota, inhibit pathogenic bacteria, and promote intestinal 





1. Introduction 1 
Constipation is a common chronic clinical gastrointestinal symptom, with high 2 
morbidity and complex pathology (Bharucha et al., 2013). Currently, an osmotic or 3 
secretory laxative is often used to relieve constipation, but it can easily cause damage 4 
to the colonic nervous system and cause additional symptoms. The gut microbiota is 5 
an important "microbial organ" of the human body, and its metabolites can regulate 6 
human health. Studies have shown that changes in the composition of gut microbiota 7 
may also increase the risk of constipation (Consortium, 2012). However, the 8 
composition of the intestinal microbiota can be modulated by the consumption of 9 
probiotics or prebiotics, which may help prevent or treat gastrointestinal diseases 10 
caused by dysbiosis of the microbiota (Rupa and Mine, 2012). Carbohydrate intake is 11 
an important factor regulating the growth of gut microbiota. In recent years, there has 12 
been a tendency to use prebiotics instead of probiotics because prebiotics have greater 13 
resistance to cross the digestive tract barrier, thy are more the cost effective and are 14 
associated with reduced safety issues (Lu et al., 2019; Shang et al., 2017). 15 
Prebiotics are defined as carbohydrates that are non-digestible by the host in the 16 
absence of gut microbiota. Prebiotics (such as fructo-oligosaccharide (FOS), 17 
isomalto-oligosaccharide (IMO) and galacto-oligosaccharide (GOS)) or compound 18 
prebiotics have an important effect on gut microbiota. They can promote the growth 19 
of some gut bacteria such as Lactobacillus and Bifidobacterium, in addition to  20 
inhibiting the growth of harmful microbiota (De Filippo et al., 2010). Some studies 21 
 
2 
have used oligosaccharides and probiotics to study heir effects on constipation in 22 
mice (Wang et al., 2017b).  23 
Lotus seeds are now used both as medicine and food in China. Lotus seeds have 24 
been used as food for regulating gastrointestinal functions in Japan, China, India and 25 
other countries for thousands of years (Guo et al., 2019). Previous studies have shown 26 
that lotus seeds contain high contents of oligosacch rides (Lu et al., 2017a). 27 
Oligosaccharides with prebiotic potential include LSO2(Gal-β-1→4-α-Glc), 28 
LSO3-1(Man-α-1→6-Glc-α-1→2-α-Fru), LSO3-2 (Man-α-1→6-Man-α-1→6-Glc-α/β) 29 
and LSO4(Man-α-1→6- Man-α-1→6-Glc-α-1→2-α-Fru) (Lu et al., 2017b). However, 30 
the mechanisms of lotus seed oligosaccharides (LOS) on intestinal regulation in vivo 31 
are still not fully understood. 32 
It is assumed that oligosaccharides can relieve constipation by stimulating the 33 
growth of beneficial bacteria or other microbiota in the intestinal tract of the host. But 34 
the mouse model of constipation induced by drugs generally cannot reflect the real 35 
microecological environment of mice under normal physiological conditions. 36 
Therefore, this study used different doses of highly purified lotus seed 37 
oligosaccharides (LOS) (mixed oligosaccharides with LSO4 : LSO3-2 : LSO3-1 : 38 
LSO2 (relative ratios: 1.107:0.554:0.183:0.443, m/m/m/m) prepared from dried lotus 39 
seed by using medium pressure liquid chromatography) or mixed lotus seed-resistant 40 
starch (LRS3) to feed healthy mice to determine the changes in the gut microbiota and 41 
the effects of LOS on the propulsion of intestinal contents in mice., Studies have 42 
shown that Bifidobacteria species have different preferences for LOS and LRS3 (Lu 43 
 
3 
et al., 2017b). Therefore, there are several aims in this study: 1) To determine whether 44 
LOS affected body weight, food intake, fecal water content, ink propulsion and 45 
production of SCFAs of BALB/c mice, 2) which oligosaccharide was most effective 46 
in relieving constipation. 3) to evaluate the relationship between composition and 47 
relative abundance of different microbiota on the serum factor and related protein 48 
expression; 4) to determine possible pathways of LOS and microbiota in relieving 49 
constipation. The results can provide possible improvement and treatment for 50 
symptoms of constipation.  51 
 52 
2. Materials and methods 53 
2.1. Materials 54 
Fresh lotus seeds were obtained from Green Acres (Fujian) Food Co., Ltd., 55 
Fujian, China. α-Amylase (10,000 U/mL) was purchased from ANKOM (New York, 56 
USA). Glucoamylase (300 U/mL) was acquired from Aladdin Reagent Co., Ltd. 57 
(Shanghai, China). Acetic acid, formic acid, and butyric acid were purchased from 58 
Aladdin Reagent Co. (Shanghai, China). Fructooligosaccharide (Meioligo-P®) was 59 
purchased from Meiji Seika Kaisha Ltd. (Tokyo, Japan) nd contained 30% 1-kestose, 60 
57% nystose, and 13% 1F-β-fructosylnystose. All other chemicals and reagents used 61 
in the experiment were analytical grade. 62 
2.2. Lotus seed oligosaccharide preparation 63 
Based on the method described by Lu et al. (Lu et al., 2017b) of collecting each 64 
monomer component of LOS (LSO4 LSO3-2, LSO3-1, LSO2) and mixing them in 65 
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the original ratio. The oligosaccharide solutions were freeze-dried after rotary 66 
evaporation (Model fd-4c-80, Beijing Fuyikang Instrument Company, Beijing, China) 67 
to obtain LOS powder. 68 
2.3. Preparation of lotus seed-resistant starch (GP-LRS3) 69 
According to the methods reported by Zeng et al. (Zeng et al., 2015). Lotus seed 70 
starch was fixed with citric acid-disodium hydrogen phosphate buffer, followed by the 71 
addition of a high temperature-resistant alpha-amylse at 90 °C in an orbital incubator 72 
shaker (SHA-C, Guo Hua Electric Appliance, Changzhou, China) at 128 rpm for 2 h. 73 
After adjusting the pH to 4.5 with a citric acid solution (4 mol/L), glucoamylase (300 74 
U/ml, obtained from Sigma, St. Louis, USA) was added (5000 U/g of starch) and 75 
incubated at 60 °C for 1 h in an orbital incubator shaker at 128 rpm. The samples were 76 
centrifuged at 3000 g for 15 min, and the supernatant was discarded. The resulting 77 
precipitate was washed with distilled water, and then the above processes were 78 
repeated twice, and then the sample was dried at 50°C and crushed and sifted through 79 
a 185-µm mesh screen. Finally, high-purity LRS (GP-LRS3) was obtained. 80 
2.4. Animal feeding trials 81 
Prior to running the experoments the animal rooms, cages and water bottles were 82 
disinfected. The temperature of the animal room stayed at 25±1 °C, the relative 83 
humidity was 60±5%, and the artificial lighting period was 12 h/day (6:00~18:00 84 
every day). Every night, the basic diet, water and disinfected bedding were replaced. 85 
Table 1 shows that the ingredients of the feed met the GB 14924.3-2010 standard of 86 
the People's Republic of China. Each mouse was housed separately to allow free 87 
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eating and to ensure the accuracy of fecal collection. For identification purposes each 88 
mouse was numbered with chrysolepic acid (Sinopharm Chemical Reagent Co., Ltd., 89 
Shanghai, China) in order. To acclimatize the mice th  animals were fed, a basic 90 
ration (specific ingredients are listed in Table 1,Jiangsu Xietong Organism 91 
Engineering Co Ltd., Nanjing, China) and water ad libitum for 1 week. Subsequently 92 
each mice was assigned to a particular diet for the experiment n=14/group. All of the 93 
animal experiments used in this study were performed in compliance with the 94 
Guidelines for the Care and Use of Laboratory Animals published by the U.S. 95 
National Institutes of Health (NIH Publication 85-23, 1996).  96 
The mice in different groups were given the above solutions at 9:00 am every 97 
morning over 15 consecutive days by gastric perfusion. The gastric perfusion volume 98 
of each mouse was 0.2 mL/10 g bw. According to the content of the Chinese Food and 99 
Drug Administration Grant No. (G20040234), the recommended dietary allowance of 100 
stachyose was 5 g/d in each adult (60 kg (bw)). The RDA of mice that weighed 20±2 101 
g was equivalent to 0.083 g/d/kg bw for humans. Thestudy divided mice into 3 dose 102 
groups that were 5, 10 and 30 times the intake of the s achyose RDA of adult humans.  103 
Eighty-four BALB/c mice (SPF level, 4 weeks of age, weight approximately 104 
16.2-17.8 g, animals certificate number: 201500052478 , SLAC Laboratory Animal 105 
Co., Shanghai, China) were randomly divided into six groups of 14 animals (50:50 106 
males:females) as follows: (1) blank control group: consumed sterile distilled water 107 
daily; (2) low dose LOS group: consumed 0.42 g/kg bw of lotus seed oligosaccharides; 108 
(3) medium dose LOS group: consumed 0.83 g/kg bw of lotus seed oligosaccharides; 109 
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(4) high dose LOS group: consumed 2.49 g/kg bw of lotus seed oligosaccharides; (5) 110 
medium dose of both LOS and LRS3 control group: consumed 0.21 g/kg bw of lotus 111 
seed oligosaccharides and were fed ad libitum with a diet of 5% resistant starch on the 112 
same day (after crushing ingredients for the basic ration shown in Table 1, the same 113 
amount of GP-LRS3 was provided instead of the 5% corn starch, followed by 114 
extrusion molding and drying to a steady mass at 50 °C); and (6) FOS control group: 115 
consumed 0.83 g/kg bw of FOS. The various oligosacch rides were dissolved at the 116 
corresponding dose in sterile water (high-pressure moist heat sterilization at 121 °C 117 
for 15 min).  118 
Fresh fecal samples were collected and placed in a dried sterile test tube every 24 119 
h immediately prior to gastric perfusion. Feeding of mice was stopped to retain fasting 120 
for 12 h before the mice were killed. The normal chow were given to ensure adequate 121 
contents in the cecum and colon, as well as to record food intake. All animal tests 122 
were according to the guidelines of and approved by the Animal Health and Use 123 
Committee of the Experimental Animal Center of Fujian Medical University (Facility 124 
license number: SCXK (Min) 2012-0001; animal ethics review table number: 125 
2017-020). 126 
2.4.1. Determination of food intake and weight gain 127 
During the experiment, mice were given adequet amounts of basic rations. 128 
According to the determination of the total feed, daily surplus feed and weight, the 129 
following formula was used to calculate daily intake and weight gain. The mice were 130 
weighed, and the daily feces were weighed by wet weight (m1). Feces were dried at 131 
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80 °C for 10 h and weighed to determine the dry weight (m2). The fecal water content 132 
(FWC) was calculated by formula (1). In addition, the daily feed intake (DFI) of each 133 







FWC  (1) 135 
DFI(g/group)=The total feed on one day(g/group)+The surplus feed on one day(g/  136 
group) -The surplus feed on next day(g/group)              (2) 137 
2.4.2. Sample collection 138 
2.4.2.1. Fecal collection 139 
During the experiment, the feces of a mouse from a single cage in each group 140 
were separately transferred to 10 mL sterile centrifuge tubes. The samples were mixed 141 
in each group and stored immediately at -80 °C in an ultralow temperature freezer 142 
(Thermo Fisher Scientific, Waltham, MA). 143 
2.4.2.2. Blood collection 144 
The blood of the mice was collected by eyeball extirpa on on the 15th day. In 145 
addition, 2 mL of arterial blood was centrifuged at 4 °C (Heraeus Biofuge Stratos 146 
Centrifuge; Thermo Fisher Scientific, Inc), and theserum collected. The blood levels 147 
of motilin, gastrin, endothelin, substance P, somatst tin, acetylcholine enzyme and 148 
vasoactive intestinal peptide in the serum of mice were tested using the following 149 
radioimmunoassay kits: motilin ELISA kit, gastrin ELISA kit, endothelin ELISA kit, 150 
somatostatin ELISA kit, acetylcholinesterase ELISA kit, substance P ELISA kit and 151 
vasoactive intestinal peptide ELISA kit(Beijing Puer Weiye Biotechnology Co., Ltd., 152 
Beijing, China). The tests were performed following the manufacturer’s instructions. 153 
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2.4.3. Intestinal content collection 154 
Each mouse was euthanized by dislocation of the cervical vertebrae. The 155 
abdominal cavity was dissected under sterile conditions to intercept the cecum and 156 
colon. The contents were placed in the 1.5 mL steriliz d centrifuge tubes with a sterile 157 
cotton swab and then weighed immediately, followed by immediate storage in a 158 
-80 °C ultralow temperature freezer. 159 
 160 
2.4.4. Determination of short-chain fatty acids (SCFAs) and lactic acid in the feces 161 
of mice 162 
Quantitative analysis was performed by the gas chromat graphy method 163 
according to the method reported by Feria-Gervasio et al. (Feria-Gervasio et al., 2011). 164 
The methodological validation of the established GC method is based on the standards 165 
of the Food and Drug Administration (FDA) for bioanalytical method validation. The 166 
lowest limit of detectability (LLOD) for each analyte was equal to 5 times the 167 
concentration (peak area) of each analyte, which was relative to the noise signal. 168 
Therefore, the minimum concentration of a standard analyte was determined, which 169 
was added to 5 blanks. (Each standard analyte was divide  to 10 concentration 170 
gradients, and each concentration was measured three tim s in parallel.) By means of 171 
determining the recovery rate to ensure the accuracy of the method, the recovery rate 172 






RR  (3) 174 
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where c1 is the tested concentration, and c2 is the known concentration of the 175 
standard sample added to the fecal culture. Inter-assay precision is the relative 176 
standard deviation percentage (% RSD), which was used to analyze the determination 177 
of each analyte from the same sample (fecal culture) on different days. Each sample 178 
was measured independently 5 times. The results showed that concentration was the 179 
horizontal coordinate and the peak area was the longitudinal coordinate for plotting a 180 
standard curve to ensure that the RSD of the standard analyte was under 5%, to 181 
determine the appropriate concentration ranges. Thestandard curve and the 182 
corresponding concentration ranges of the test are shown in Supplementary Table 1. 183 
For analysis, 0.5000 g feces was put in a 5 mL centrifuge tube. After cooling in 184 
an ice bath for 10 min, 4 mL of sterilized deionized water was added and then stirred 185 
by magnetic rotation for 2 min or longer until the feces was completely dissolved. The 186 
fecal suspension was centrifuged at 5000×g (4 °C) for 20 min. The resulting 187 
supernatant was centrifuged again. The second centrifuged supernatant was collected 188 
and then injected into a 1.5 mL sample bottle after filtering through a 0.45 µm mesh. 189 
Three independent replicates were carried out for each sample. The content of SCFAs 190 
in the feces was determined under the same GC-MS conditions. The total SCFA 191 
concentration was the sum of the concentrations of acetic acid, lactic acid, propionic 192 
acid and butyric acid in feces. 193 
 194 
2.4.5. Extraction of DNA from fecal microbiota of mice and analysis of PCR 195 
products by denaturing gradient gel electrophoresis (DGGE) 196 
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According to the methods reported by Zhou et al. (Zhou et al., 2014). 197 
 198 
2.4.6. Analyses of diversity, homogeneity and principal components 199 
The DGGE profiles were analyzed by QUANTITY ONE (version, 4.3.0, 200 
Bio-Rad, Laboratories, Inc, USA) for quantitative analysis of the number of 201 
electrophoretic bands and the density of the bands. The results were used for analyses 202 
of diversity and principal components of intestinal nd fecal microbiota. The 203 
Shannon-Weiner index (H), abundance (S) and the valance index (E) were used to 204 
compare the diversity of different treated bacteria. The specific algorithms are shown 205 






















==     (5) 208 
∑= inN  (6) 209 
where H is the Shannon-Weiner index (0<H lnS); EH is the evenness index; pi is 210 
the ratio of the grayscale of a single band to the total strength of all the bands of the 211 
sample; Ni is the abundance of the i-th band; and S is the sum of all the bands in the 212 
sample. The major components of the microbiota structu e were analyzed according 213 
to the brightness and position of the different bands by CANOCO software. 214 
Subsequently, the sequences were submitted to the GenBank database. The Blast 215 
procedure in GenBank was used to compare homologies and obtain the 16S rDNA 216 
sequences of the most similar strains. The neighbor-joining method by MEGA version 217 
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5.0 software was used to construct phylogenetic trees, and the bootstrap number was 218 
1000. 219 
 220 
2.5. Evaluation of the promotion of the fecal excretion function in mice 221 
2.5.1. Preparation of ink and loperamide hydrochloride solution 222 
The experiment was performed according to the "verificat on method of laxative 223 
function" of the "Technical specifications of health food inspection and evaluation, 224 
version 2003" from China. Accurately weighed 100 g gum arabic was mixed with 800 225 
mL water and boiled until the solution became transp rent. Activated carbon (powder) 226 
(Sinopharm Chemical Reagent Co., Ltd., Shanghai, China) was weighed, and 500 g 227 
was mixed with the above solution. The solution was boiled 3 times, and distilled 228 
water was added up to 1000 mL when the solution was cold. Then, the solution was 229 
stored in the refrigerator at 4 °C and shaken well b fore using.  230 
 231 
2.5.2. The excretion time of black feces  232 
Ninety-eight mice from the same source were divided into seven groups and 233 
subjected to gastric perfusion as described below. Mice of each group were injected 234 
with 10% ink by gastric perfusion at 9 o'clock every morning from the seventh day up 235 
to the 15th day; all mice were injected with ink bygastric perfusion after 24 h of 236 
fasting. The volume of perfusion of each mouse was 0.2 mL/10 g bw. The blank 237 
control group were injected with the same mass of gum arabic (0.2 mL/10 g bw) 238 
without ink. The model group (MOG) were injected with the same volume of 239 
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loperamide hydrochloride solution by gastric perfusion. The mice in each group were 240 
used to determine the time of first excretion of black feces. Finally, the mice were 241 
euthanised and autopsied after the gastric perfusion of ink. 242 
 243 
2.5.3. Small intestine ink propulsion experiment 244 
Mice were euthanised by dislocation of the cervical vertebrae after gastric 245 
perfusion of ink. The abdomen was dissected and the mesentery of the mouse was 246 
separated. In addition, the whole intestine from the pylorus to the ileocecal was 247 
clipped. The whole small intestine was straightened i to a line on absorbent paper to 248 
measure the length of the intestine, which was the total length of the small intestine. 249 
The length from the pylorus to the front of the inkwas the "ink propulsion length". By 250 
measuring the ink propulsion length in the small intestine, the propulsion rate was 251 
calculated according to formula below (7). 252 
%100
intestine small ofLength 
ink of distance Moving
(%) rate propulsion intestine Small ×=      (7) 253 
 254 
2.5.4. Determination of reverse transcription PCR (RT-PCR) 255 
Total RNA was extracted from tissue by Trizol (Invitrogen, Carlsbad, CA, USA). 256 
After determining the purity by ultraviolet radiation, the concentration of total RNA 257 
was adjusted to the same level in each group. The same amount of RNA (2 µg) from 258 
the sample was added to1 µL oligodT18, RNase, and dNTP and 10 µL 5× buffer MLV 259 
enzyme (Promega, Wisconsin, USA). The cDNA was synthesized in 10 µL body 260 
fluids for 120 minutes at 99 °C, for 4 minutes at 4 °C, and for 3 minutes at 37 °C. 261 
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Reverse transcription and amplification were performed for the target genes c-Kit, 262 
stem cell factor, glial cell line-derived neurotrophic factor, transient receptor potential 263 
vanilloid 1, and nitric oxide synthase (Supplementary Table S2). Quantitative 264 
real-time RT-PCR was performed using an Applied Biosystems Sequence Detection 265 
System 7900 (ABI Prism 7900HT, Applied Biosystems, Foster City) with 10 mL of a 266 
mixture comprising Power SYBR GREEN PCR Master Mix (Applied Biosystems), 267 
500 nmol of each primer and 300 ng of the complementary DNA template. The 268 
reaction conditions were denaturation at 95 °C for 5 min, annealing at 58 °C for 50 s, 269 
extension at 72 °C for 90 s and cycling the above steps 40 times. Finally, the sample 270 
was extended at 95 °C for 10 min Then, the expression of the final product was 271 
determined by 2% agarose gel electrophoresis. qRT-PCR and data collection were 272 
performed by the ABI PRISM 7900HT sequence detection system. 273 
 274 
2.5.5. Determination by western blots 275 
According to the methods reported by Li et al. (Li et al., 2017), protein lysate 276 
was added to the tissues, and the sample was washed wit  precooled PBS three times. 277 
The resulting mixture was decomposed at 4 °C and cetrifuged (9000 g/min) for 15 278 
min. Then, the supernatant containing protein mixed with buffer was extracted by 279 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). A primary 280 
antibody was placed in the solution after SDS-PAGE and moved to a polyvinylidene 281 
fluoride (PVDF) membrane. The protein was kept at 4°C overnight. The horseradish 282 
peroxidase-conjugated secondary antibodies were incubated with protein at room 283 
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temperature. Finally, the immunoreactive protein was tested by an enhanced 284 
chemiluminescence assay kit (GE Healthcare, Uppsala, Sweden), and β-actin was the 285 
internal reference. The bands were displayed by an enhanced chemiluminescence 286 
system (ECL, Thermo Fisher Scientific, MA, USA) and LAS image software (Fuji, 287 
New York, NY, USA). 288 
 289 
2.5.6. Statistical analysis 290 
The figures were drawn by the software Origin Pro 9.0 (Origin Lab Corporation, 291 
USA). All statistical analyses were performed using Data Processing System software 292 
(DPS, V9.05, Science Press, Beijing, China). One-way ANOVA, followed by 293 
Duncan's post-hoc test, was used to determine the significant differences between 294 
treatment groups. p<0.05 was considered statistically significant; alltests were 295 
two-sided, and no corrections were applied for multiple significance testing. All the 296 
experiments were repeated at least three times. All distributions are represented as the 297 
mean value ± standard deviation. 298 
 299 
3. Results and Discussion 300 
3.1. Effects of lotus seed oligosaccharides on mouse weight  301 
The effects of oligosaccharide and resistant starch on mice weight are shown in 302 
Figure 1A. During the experiment, the mice were healt y. Their fur was smooth and 303 
did not fall out, the defecation was regular and no mice unexpectedly died or became 304 
ill. As the experiment progressed, the weights of muse increased. After the 15th day, 305 
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the weight gain sequence was the blank control group>l w dose of LOS 306 
group>medium dose of LOS group>FOS control group>high dose of LOS 307 
group>medium dose of both LOS and LRS3 control group.  308 
Compared to the NG, the weight gain of mice injected with increasing doses of 309 
lotus seed oligosaccharides by gastric perfusion was significantly reduced. In the first 310 
11 days, the weight gain of mice fed LOS was higher t an that of the blank control 311 
group. Feeding LOS and FOS was beneficial for keeping the mouse weights stable. 312 
This result was in accordance with the result obtained by Caroline Thum et al. (Thum 313 
et al., 2016). Feeding with caprine milk oligosaccharides and GOS may help to 314 
increase the weight in early stages and extend the growth cycle and muscle mass of 315 
the weaning period in mice. In the medium term of 30 days, the main form of 316 
metabolism slowly turned to carbohydrate metabolism. Oligosaccharides increased 317 
short-term weight gain and produced insulin resistance through intestinal intake, and 318 
the glucose transport protein expression pathway was changed. These differences 319 
persisted into adulthood (Thum et al., 2016). Mice fed with both LOS and LRS3 had 320 
the lowest weight gain. This may be related to satiety and low food intake caused by 321 
feeding with oligosaccharides and resistant starches. Dietary fiber and some FOS 322 
were proven to limit fat storage. This is mainly reflected by the inhibition of 323 
short-term food intake.  324 
The influence of food intake of mice is shown in Figure 1B. After 15 days, the 325 
sequence of food intake in different groups was the blank control group>low dose of 326 
LOS group>FOS control group>medium dose of LOS group>high dose of LOS 327 
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group>medium dose of both LOS and LRS3 control group, which was similar to the 328 
tendency of weight change in the mice. However, compared to the mouse feces from 329 
the FOS positive or blank control groups, feeding with high doses of LOS and 330 
LOS-LRS3 mixture helped mice to reduce weight gain and food intake. After that, the 331 
intake of mice in all treatment groups increased slowly. This phenomenon showed that 332 
food intake was an important factor on the mouse weight change.  333 
The feces water content of all animals sustained a high water content (Figure 1C). 334 
Functional oligosaccharides and resistant starch induce intestinal microbiota to 335 
produce SCFAs to acidify the contents of the intestinal tract. This results in 336 
stimulating the intestinal peristalsis and increasing the moisture content of feces. If the 337 
fecal water content was high, the fecal propulsion was so good that it reflected good 338 
gastrointestinal motility. Additionally, the possibil ty of constipation was reduced in 339 
these mice(Thum et al., 2016). 340 
 341 
3.2. Microbiota structure of diversity results in mice 342 
PCR-DGGE technology is widely used to monitor microbial community 343 
diversity and population dynamics. The different bands represent different bacterial 344 
famalies in each lane. The structure and relative quantity of the bacteria in the 345 
intestinal track and feces of the LOS-treated mice is shown in Figure 2. The letters 346 
and numbers represent different lanes and band numbers, respectively. Different 347 
positions of the lanes represent different gut microbial species. The more bands 348 
present was the more abundant number of microbial families or genus in the sample.. 349 
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The brighter the highlight, the greater the number of corresponding strains represented 350 
by the bands. It was shown by the gray value of the band 2B that the bacteria in each 351 
band were well separated. Thirty-two clear bands were identified from positions in 352 
seven lanes. The standard was the blank control group in which the number of 353 
famalies was 100%. The next highest number of families was in the FOS control 354 
group (72%) and cecum groups with a medium dose of LOS treatment by gastric 355 
perfusion. The lowest microbial diversity was in the colon group with a medium dose 356 
of LOS treatment by gastric perfusion. The dose effct was not obvious in the low 357 
dose group, medium dose group and high dose group most likely because high doses 358 
of LOS would inhibit the growth of some species (The relative abundance of families: 359 
medium dose group>low dose group>high dose group). From the specific distribution 360 
of the profiles, the blank and FOS control groups were similar to the low dose of LOS 361 
group, and there were little differences between th colon and cecum samples of mice 362 
from the mice of medium dose of LOS groups, the high dose of LOS group and the 363 
medium dose of both LOS and LRS3 control group. This indicated that there was no 364 
difference in the structure of the bacterial community among these samples. It also 365 
showed that a low dose of LOS had little effect on the gut microbiota of mice. The 366 
relative abundance of families in the colon and cecum of mice was similar and in this 367 
regard the microbiota in the mouse intestinal tract differs from that of humans. The 368 
human intestinal fermentation area is located in the colon, while the microbiobial   369 
fermentation in mice is located mainly in the cecum (Campbell et al., 1997). 370 
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Therefore, microbial abundance of the cecum was highest as evidenced by the higher 371 
number of electrophoretic bands. 372 
The bacterial structure of the diversity analysis re ults is shown in Table 2. The 373 
diversity index was used to evaluate the diversity of bacteria. In addition, evenness 374 
was used to indicate the average levels of distribution of species. The result shows 375 
that compared to the blank control group, there was no ignificant difference between 376 
evenness of different samples. The results showed that the distribution of the 377 
microbiota in the intestinal tract and feces was uniform before and after gastric 378 
perfusion of LOS, mixture and FOS. However, the diversity index and abundance of 379 
the gastrointestinal and feces samples of oligosaccharides treated mice were higher.380 
 These results showed that oligosaccharides could reduce the diversity of bacterial 381 
composition in the gastrointestinal of mice after digestion. This is probably because 382 
the bacteria from different species respond differently to the polysaccharides injected. 383 
The species with strong tolerance to high doses of oligosaccharides survived while the 384 
viability of families such as with poor tolerance rduced. As a result, there was 385 
reduced diversity of the microbiotain those groups fed oligosaccharides and resistant 386 
starch. In addition, these results may also be related to the impact of some groups of 387 
bacteria on each other such as antagonism and growth promotion. Compared with the 388 
colon groups and medium dose of LOS group, the diversity index of cecum and 389 
medium dose of LOS groups were higher. It showed that e microbial diversity 390 
increased as fecal propulsion progressed in the intest al tract, while the medium dose 391 
of both LOS and LRS3 control group had a lower diversity. It was shown that the 392 
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addition of LSR3 was helpful to the formation of dominant families in the gut 393 
microbiota of mice. 394 
According to the UPGMA algorithm, a similarity analysis of sample bands was 395 
performed. The genetic similarity Jaccard index was used to represent the genetic 396 
relationships among bands. From Figure 3A, the microb ota of colon and cecum 397 
groups were most similar, (Jaccard index reached 0.84). The next was the high dose of 398 
LOS group and the FOS control group. The results showed that the high dose of LOS 399 
could change the gut microbiota composition of mice, which was similar to the effect 400 
of FOS. The Jaccard index of the medium dose of both LOS and LRS3 control group 401 
and the previous two groups was 0.70. The gut microb ota of the high dose of LOS 402 
group and medium dose of both LOS and LRS3 control g up may have as many 403 
bacterial structures as the FOS group in the intesti al tract of mice. Figure 3B shows 404 
further differences in the composition of intestinal and fecal bacterial structures in 405 
mice with different treatments. The closer the test points on the PCA distribution 406 
figure, the greater the similarity of the bacterial composition. The medium dose of 407 
both LOS and LRS3 control group was mainly distributed in the first quadrant; The 408 
high dose of LOS group and the FOS control group were mainly distributed in the 409 
second quadrant; The blank control group, low dose of LOS group, and medium dose 410 
of LOS group were distributed in the third quadrant; and the colon and cecum groups 411 
were mainly distributed in the fourth quadrant. In different quadrants, the bacterial 412 
diversity of treatment groups was similar. The results of the PCA analysis were 413 
consistent with the clustering analysis of bacterial community structure. Except for 414 
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the low dose of LOS group, the bacterial structure of the mice in different dose groups 415 
was different to that of the blank control group. This indicated that the intake of 416 
oligosaccharides is the main factor affecting the microbiota. The medium dose of both 417 
LOS and LRS3 control group, colon and cecum groups clu tered together. The results 418 
showed that the structure of the carbon source fed and the animal tissue areas might 419 
be important factors affecting the quantity and comp sition of gut microbiota. 420 
 421 
3.3. DGGE gel band-recovered sequence analysis results 422 
The bands were sequenced by gel-cutting, and homogeneity analysis was 423 
performed on the NCBI website. Exact analysis results are shown in Table 3. Bands 424 
were selected for gel sequencing. The results were compared in the NCBI website and 425 
used to perform phylogenetic analysis. Compared with data from Table 3 and Figure 2, 426 
the sequencing results showed that compared with the blank control group, groups 427 
given oligosaccharides or resistant starches, even with increasing doses of LOS, had 428 
significantly decreased numbers of Erysipelotrichaceae in the intestinal tract of mice 429 
(band 1). The decrease in Erysipelotrichaceae could be beneficial because blooms in 430 
Erysipelotrichaceae numbers have been reported in some patients with metabolic 431 
disorders such as obesity or steatosis or in an animal model of colorectal cancer, but 432 
the causative links are not established (Zhu et al., 2014b). 433 
Bands 2, 3 and 8 belonged to the Bacteroidaceae family, which had a greater 434 
number in the colon and cecum groups, which was slightly increased in the high dose 435 
of LOS group, the medium dose of both LOS and LRS3 control group and the FOS 436 
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control group. Bacteroides acidifaciens (band 2) was high in the high dose of LOS 437 
group, and Bacteroides oleiciplenus (band 8) was high in the low dose of LOS group. 438 
Bacteroides can degrade carbohydrates and metabolic intermediates. At the same time, 439 
they can produce SCFAs, such as acetic acid, lactic id, propionic acid, and other 440 
fatty acids. The increased number of Bacteroides acidifaciens has been shown to 441 
significantly reduce body weight and body fat content in mice. It has the potential to 442 
treat traditional metabolic diseases such as diabetes and obesity (Yang et al., 2017). 443 
The carbohydrates promoted the growth of Bacteroides graminisolvens. Bacteroides 444 
oleiciplenus is an obligate anaerobic bacterium, which was isolated from human feces. 445 
It can metabolize glucose into acetic acid, succini acid, formic acid and lactic acid 446 
(Watanabe et al., 2010). High concentrations of LOS can inhibit its growth in mouse 447 
feces in this study. 448 
Bands 4, 11, 19, 20, 23, 29, 30 and 32 belonged to the Porphyromonadaceae 449 
family. It is one of the dominant families in human feces. Porphyromonadaceae is 450 
generally involved in complex carbohydrate and protein fermentation (Wang et al., 451 
2016). Except for bands 23 and 29, compared with the blank control group, the 452 
relative proportion of Porphyromonadaceae decreased ignificantly after LOS 453 
treatment by gastric perfusion. The relative abundance of Porphyromonadaceae 454 
decreased at high carbohydrate concentrations. If the number of Porphyromonadaceae 455 
increased to a certain extent, it may have led to cognitive deficits (Wang et al., 2017b). 456 
However, the presence of Parabacteroides distasonis reduces the possibility of colitis. 457 
Resistant starch contributed to increasing the number of Parabacteroides distasonis 458 
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(Martínez et al., 2010). This may be one of the reasons that a high abundance of 459 
Parabacteroides distasonis was in the medium dose of both LOS and LRS3 control 460 
group. In addition, high doses of LOS gastric perfusion also help to enhance the 461 
abundance of Parabacteroides distasonis. 462 
The Lachnospiraceae family (bands 5, 7, 12, 14, 15, 16, 17 and 31) contains 463 
Butyrivibrio, Lachnospira and Roseburia species. and was detected at high relaive 464 
abundance in the colon and cecum of mice. These genra are assocatied with the 465 
fermentation of a variety of carbohydrates, but it cannot metabolise amino acids.. 466 
Lachnospiraceae is abundant in the digestive tract of many mammals. This family is 467 
associated with the production of butyric acid in the gastrointestinal of humans, which 468 
is an important for both for the growth of microbiota and host epithelial cells. Some 469 
studies have shown that it may play a role in the prevention of obesity and colon 470 
cancer in humans (Meehan and Beiko, 2014). Butyrivibrio species were associated 471 
with bands 12 and 14. andand correlated with the high dose of LOS and ORG group. 472 
This species is known to produce SCFA such as lactic, acetic and butyric acids.  473 
The Clostridiaceae family was identified from bands 6, 22, 24 and 26 LOS by 474 
gastric perfusion significantly decreased the relative abundance of a number of 475 
Clostridiaceae. Clostridiaceae colonizes the gastrointestinal of infants in addition to 476 
the strict anaerobic bacterium such as Bifidobacteriac ae a few days after birth. Until 477 
the age of 1, Clostridiaceae dominates the microbiota (Wegh et al., 2017). Clostridium 478 
thermosuccinogenes (band 6) produced acetic acid, lactic acid, succini  acid, and H2 479 
through the fermentation of inulin. The metabolites of Clostridium sporosphaeroides 480 
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(band 22) were a large amount of acetate and butyrate, and a small amount of. 481 
Clostridium xylanovorans (band 26) can ferment raffinose, sucrose, xylan, mannitol, 482 
cellobiose, galactose, mannose and melibiose to produce formate, acetate, butyrate, H2483 
CO2, isopropyl butyrate and ethanol (Mechichi et al., 1999). Clostridium grantii (band 484 
24) can ferment alginate, cellobiose, glucose, maltose, mannose and fructose to 485 
produce acetate, ethanol, formate, and carbon dioxide (Rainey et al., 2015).  486 
Bands 13 and 21 were both Ruminococcaceae, belonging to the Firmicutes 487 
phylum. The ratio Firmicutes and Bacteroidetes phyla as an important relationship to 488 
human obesity. It has been shown that obese subjects had approximately 20% more 489 
Firmicutes than those who were thinner. At the same time, obese subjects had 490 
approximately 90% less Bacteroidetes than the thinner subjects. Bacteroidetes phylum 491 
of Runinococcaceae was also one of the bacteria producing SCFAs that inhabited the 492 
cecum and colon of mammals. Ruminococcaceae is responsible for the degradation of 493 
various polysaccharides and fibers. In addition, the relative proportions of 494 
Ruminococcaceae is related to the prevention of alcohol hepatitis, nonalcoholic 495 
hepatitis, hepatic encephalopathy, and increases of intestinal permeability (Shang et 496 
al., 2016). DGGE results showed that LOS could significantly increase the number of 497 
Anaerotruncus colihominis in the mouse colon and cecum (band 13); mixed prebiotics 498 
and FOS could also increase the number of this bacteri  in feces. 499 
Bands 9 and 10 were Rikenellaceae and Alistipes, a genus in the Rikenellaceae 500 
family. If the relative proportion of Rikenellaceae increases to a certain extent, it may 501 
induce the body's systemic infectious diseases (Boente t al., 2010). After gastric 502 
 
24 
perfusion of LOS, the abundance of Rikenellaceae decreased significantly. In addition, 503 
the relative proportions of Rikenellaceae in the colon and cecum were not high. This 504 
may be because oligosaccharides inhibit the adhesion of pathogens to the surface of 505 
the epithelial cells of the host (Kunz et al., 2000). 506 
Band 18 belonged to the Helicobacter genus Helicobacter is commonly 507 
associated with other bacteria in a symbiotic relationship in the gastrointestinal mucus. 508 
(Zhang et al., 2006). Helicobacter inhabit the colon, where high numbers it can 509 
adversely affect the intestinal health (Muyzer et al., 1993). Compared to the blank 510 
control group, the relative proportion of Helicobacter was significantly reduced 511 
(p<0.05) after gastric perfusion of LOS. Dietary carbohydrates, such as the 512 
oligosaccharides, 2-fucosyllactose and 3-fucosyllactose from breast milk, and 513 
polysaccharides such as laminaran and alginate had been shown to inhibit 514 
Helicobacter in mice (Nakata et al., 2016; Weiss et al., 2014). 515 
Band 25 belonged to the Oscillospiraceae f mily, which was preeent at low 516 
relative abundance in the low dose of LOS group. Oscillo piraceae are anaerobic 517 
bacteria and are involved in the production of leptin and butyrate, and some bacteria 518 
have the capacity to utilize glucuronic acid (Gophna et al., 2017). Band 27 belonged 519 
to the Sphingomonadaceae family. Similar to band 25, the abundance was high in the 520 
low dose of LOS with gastric perfusion. Sphingomonadaceae are found in fresh cut 521 
fruit and vegetable products (Gorni et al., 2015). Therefore, it may be derived from 522 
the daily routine of the mouse's diet. In addition, the bacteria were also found in the 523 
intestinal tract of healthy and elderly people (Yu et al., 2015). Band 28 belonged to the 524 
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Desulfovibrionaceae family; compared to the blank control group, the relative 525 
abundances of members of this family in the high dose f LOS group, the medium 526 
dose of both LOS and LRS3 control group and the FOScontrol group were decreased 527 
significantly. The genome of Desulfovibrio desulfuricans contains pathways from 528 
choline to the choline utilization gene and cluster of trimethylamine. Thus, it is an 529 
intestinal microbiota that may promote atherosclerosis in humans (Matsumoto et al., 530 
2017). 531 
In summary, medium to high doses of LOS and mixed pr biotics could enrich the 532 
growth of families that produce SCFAs, such as Bacteroidaceae, Lachnospiraceae, 533 
Clostridiaceae in mice. They can also reduce the number of other families such as 534 
Erysipelotrichaceae, Porphyromonadaceae, Rikenellaceae, Desulfovibrionaceae and 535 
Helicobacter. The acetate and butyrate in SCFAs have an important effect on intestinal 536 
mucosal biology (Bultman and Jobin, 2014). Therefor, it may have a potential 537 
positive effect on the proliferation of human epithelial cells and mucosal immune 538 
response. 539 
 540 
3.4. Effects of LOS on SCFAs in mice feces 541 
The total SCFA content in mice feces treated with LOS is shown in Figure 4. The 542 
SCFA content was higher than that of the blank control group after oligosaccharide 543 
gastric perfusion (p<0.05), while that of the medium and high dose of LOS groups 544 
had no significant differences (p>0.05). There was no difference between the high 545 
dose of LOS group and the FOS control group. In addition, there was no difference 546 
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between the medium dose of both LOS and LRS3 control group and the medium dose 547 
of LOS group, and they showed no greater ability to produce SCFAs. 548 
Oligosaccharides can promote the proliferation of probiotics in the cecum, while 549 
resistant starch can only significantly enhance the proliferation of probiotics in the 550 
colon (Rodríguez-Cabezas et al., 2010). When the dose of LOS and LRS3 were 551 
basically the same, the total SCFA content of the medium dose of both LOS and LRS3 552 
control group was almost unchanged. A high dose of LOS can increase the number of 553 
Bacteroidaceae, Lachnospiraceae, Clostridiaceae, Ruminococcaceae and other 554 
bacteria.  555 
However, the specific families were different, and the bacterial families were 556 
more diverse. LOS and LRS3 mixed prebiotics increased the relative proportions of 557 
families such as Bacteroidaceae, Lachnospiraceae, and Ruminococcaceae. The 558 
primary bacteria were the butyric acid-producing bacteria Lachnospiraceae. 559 
Bacteroidaceae and Ruminococcaceae mainly produce acetic acid and lactic acid. 560 
These bacteria were the main SCFA-producing bacteri. SCFAs were beneficial to 561 
reduce intestinal pH in mice, which inhibited the growth of gut pathogenic 562 
microbiota. 563 
 564 
3.5. Effect of LOS on the intestinal transit in mice 565 
Constipation can cause abdominal pain and bloating, which is due to reduced 566 
defecation, caused by feces that are difficult to pass through the intestinal tract. Most 567 
often, constipation occurs after feces slowly passed through the digestive tract. 568 
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Constipation is caused by many reasons, including medications, defecation habits, low 569 
fiber diet, abuse of laxatives, hormonal imbalance, and other diseases in different 570 
parts of the body. Constipation causes a large amount f water in the feces to be 571 
absorbed by the intestinal track during the slow movement, leading to feces that are 572 
hard and dry. Fecal status, food intake, water consumption and defecation time are 573 
important criteria for the study of constipation. I this study, a mouse constipation 574 
model was established as a positive control group by administering loperamide 575 
hydrochloride. The results of the small intestine peristalsis test showed that the ink 576 
propulsion rate in mice treated with high doses of LOS and LOS-resistant starch 577 
mixture was significantly higher than that of mice in the constipation control group 578 
(Figure 5, p<0.05). The results of the medium dose of LOS group and the FOS 579 
control group were similar. It was shown that LOS and LRS3 can promote intestinal 580 
peristalsis, and intestinal contents move toward the colon during defecation. By 581 
measuring the defecation time of the first black feces in mice, it was found that the 582 
defecation time of mice in the high dose of LOS group and the medium dose of both 583 
LOS and LRS3 control group were significantly shorter than that of the constipation 584 
control mice (p<0.05). This suggested that LOS and resistant starch can significantly 585 
shorten the residence time of intestinal contents, thereby relieving constipation. The 586 
effects on defecation of the mice of medium dose of LOS group and the FOS control 587 
group were similar. The mice in low dose of LOS group were better than the model 588 
group. It was notable that after adding the LRS3, LOS greatly improved defecation 589 
time. Compared to the blank control group, the defecation time of the first black feces 590 
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was significantly reduced (p<0.05). However, the ink propulsion rate was not the 591 
highest one measured. This may be because resistant starch can increase fecal volume 592 
and water content, and the increased fecal volume slows down the rate of propulsion. 593 
However, feces were soft and easily moved to the anus and excreted, shortening the 594 
transportation time. Supplementation with LOS had better effects on the prevention of 595 
constipation. Other oligosaccharides had similar results. For example, studies in 596 
humans showed that the supplement isomaltooligosaccharide increased the frequency 597 
of spontaneous defecation and the total mass of feces of constipated elderly subjects 598 
(Yen et al., 2011). In addition, FOS and GOS (a FOS preparation with 95% FOS 599 
(FOS95); GOS preparation with 90% GOS (GOS90) and IMO) had similar effects 600 
(Wang et al., 2017b). Some probiotics, such as Streptococcus thermophilus, 601 
Bifidobacterium sp and Lactobacillus sp prevented or treated constipation. 602 
Anti-constipation mechanisms of oligosaccharides may be due partly to 603 
oligosaccharides remaining in the intestines and increasing the number of beneficial 604 
gut microbiota. Oligosaccharides reduce the pH in the colon and inhibit the growth of 605 
harmful bacteria. This low pH increases the water content and mass of the feces and 606 
contributes to the intestinal peristalsis (MacDonald and Wagner, 2012). 607 
 608 
3.6. Motlin, Gastrin, Endothelin, Somatostatin, Acetylcholine enzyme, Substance P 609 
and Vasoactive intestinal peptide levels in serum 610 
The results of the related serum factors showed that motlin, gastrin, endothelin, 611 
acetylcholine enzyme, substance P and vasoactive intesti al peptide of the model 612 
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group were significantly lower than those of the normal group (p<0.05). The 613 
somatostatin level was significantly higher than that of the blank control group 614 
(p<0.05). Compared to the model group, the three doses f LOS were able to increase 615 
the motlin, gastrin, endothelin, acetylcholine enzyme, substance P and vasoactive 616 
intestinal peptide levels in serum disproportionately and reduce somatostatin factor 617 
levels. The effect of the high dose of the LOS group was the strongest, and the effect 618 
of medium dose of both LOS and LRS3 control group was closest to the blank control 619 
group. As shown in Figure 6, the results showed that different types of LOS and 620 
resistant starch could stimulate some hormones, such as motlin, and some 621 
neurotransmitter levels in mouse serum. The secretion of somatostatin was reduced, 622 
and then stimulation of the intestinal nerve, promotion of intestinal peristalsis and 623 
increased intestinal osmotic pressure, maintenance of the secretion of vascular tension, 624 
water and digestive juice (gastric acid, pancreatic juice and bile, etc.) led to relaxation 625 
of the pyloric sphincter so that it can be used for easy defecation. Probiotic 626 
composition may play an important role in neurotransmitter changes in intestinal 627 
peristalsis.  628 
 629 
3.7. Gene expression and the protein expression of c-Kit, Stem cell factor, 630 
Transient receptor potential vanilloid 1, Glial cell line-derived neurotrophic factor 631 
and Nitric oxide synthase 632 
Interstitial cells of cajal are mesenchymal cells between the gastrointestinal 633 
nervous system and the smooth muscle in gastrointestinal. They are neurotransmitters 634 
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between the pacemaker cells and neuromuscular cellsduring the gastrointestinal 635 
motility. They play an important role in regulating the intestinal neural signal in 636 
smooth muscle cells. Interstitial cells of cajal receive neurotransmitters through 637 
receptors (such as vasoactive intestinal peptide and substance P) and then transfer 638 
receptors to adjacent smooth muscle cells through the gap junction to produce colon 639 
motility (Wang et al., 2013). C-Kit is a membrane rceptor of stem cell factor 640 
expressed by interstitial cells of cajal, which has tyrosine kinase activity. C-Kit is a 641 
specific marker of interstitial cells of cajal and is interdependent with stem cell factor. 642 
Under normal conditions, c-kit is a monomer that exists in the cell membrane and 643 
activates cellular signaling pathways, which are essential for normal cell growth and 644 
development. The expression of c-Kit mRNA and c-Kit proteins are significantly 645 
decreased in colon interstitial cells of cajal of patients with chronic constipation 646 
(Yuzawa et al., 2007). As shown in Figure 7A, Figure 7B and Figure 8, compared to 647 
the model group, the levels of the c-Kit and stem cell factor gene were significantly 648 
increased by LOS gastric perfusion (p<0.05). The higher the concentration of LOS 649 
provided, the greater increase in c-Kit and stem cell factor expression levels. The 650 
effect of medium dose of both LOS and LRS3 control gr up was the strongest. The 651 
expression of mRNA and its corresponding protein of stem cell factor was also 652 
activated. Increased expression of transient receptor potential vanilloid 1 may be a 653 
sign of intestinal injury. Nitric oxide synthase is the key to the production of 654 
endogenous NO from the esophagus to the anal sphincter. Nitric oxide synthase 655 
control can reduce the amount of NO, which is a feasible way to control constipation. 656 
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Glial cell line-derived neurotrophic factor is an active protein factor that can control 657 
the growth and development of nerve cells and protect and repair damaged nerve 658 
fibers. Glial cell line-derived neurotrophic factor can enhance the content of factor 659 
and then repair the damaged intestinal tract to avoid c nstipation. Transient receptor 660 
potential vanilloid 1, glial cell line-derived neurot ophic factor and nitric oxide 661 
synthase genes were important intestinal nerve-related genes. LOS and LRS3 altered 662 
the mRNA and protein expression of transient receptor otential vanilloid 1, glial 663 
cell line-derived neurotrophic factor, and nitric oxide synthase. After feeding with 664 
oligosaccharides and resistant starch, the expression of the mRNA and protein of glial 665 
cell line-derived neurotrophic factor was increased ignificantly (p<0.05) in treated 666 
mice, while the expression of transient receptor potential vanilloid 1 and nitric oxide 667 
synthase had a contrasting tendency, resulting in inhibiting constipation. In addition, 668 
nitric oxide synthase inhibited the release of acetyl holine enzyme. The above three 669 
factors maintained a balance of intestinal motility under LOS feeding.  670 
The medium dose of both LOS and LRS3 control group contained a high 671 
concentration of SCFAs, but the intestinal propulsion time was longer and there was a 672 
lower level of expression of associated protein in the medium and high dose of LOS 673 
groups. This differed from the conclusion that the concentration of SCFAs in the 674 
intestine can relieve constipation (Wang et al., 2017a). Dietary fiber content may 675 
cause differences. It was not found that the higher t  content of SCFAs, had a better 676 
effect on defecation. High concentrations of butyric acid can inhibit secretion of 677 
mucin in intestinal goblet cells or reduce fecal voume by stimulating absorption of 678 
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water and electrolytes in the colon (Zhu et al., 2014a). This may be due to different 679 
compositions between gut microbiota and fatty acids. For example, the medium and 680 
high dose of LOS groups, the high dose of LOS group and the medium dose of both 681 
LOS and LRS3 control group significantly reduced the content of Oscillospiraceae 682 
(band 25). The bacteria affected the metabolism of nutrient fiber, which was 683 
conducive for defecation (Konikoff and Gophna, 2016). The effects of a high dose of 684 
LOS on gut microbiota in mice were similar to those f FOS. This can be attributed to 685 
the different structures and composition of each monomer of LOS (LSO4, LSO3-2, 686 
LSO3-1, LSO2; relative ratios are 1.107:0.554:0.183:0.443). Different 687 
monosaccharide contents, glycosidic bonds and polymerization degrees may influence 688 
the different composition of gut microbiota. Therefor , relevant work is needed for 689 
further study at the next stage. A concurrent reference control group received 690 
2.49 g/kg bw/day of oligosaccharides already used in FOS (a permitted food 691 
ingredient (EC, 2006, US FDA GRAS GRN Notice 000044, US FDA, 2000a, US 692 
FDA, 2000b)), for direct comparison with the high-dose LOS group. There were no 693 
treatment-related effects of LOS on survival, clinial observations, body weight, body 694 
weight gain, food consumption, food efficiency, hematology, microbial composition. 695 
Comparison to several HMOs currently approved as ingredients and infant 696 
formula/follow-on formula uses indicates that LOS has the similar safety profile, 697 
based on the current studies presented here (Coulet et al., 2013; Phipps et al., 2018; 698 
Pitt et al., 2019). No evidence of toxicity was observed and in the absence of 699 
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compound-related adverse effects in the study. These r ults may support the use of 700 
LOS as a nutritional ingredient for food use. 701 
4. Conclusions 702 
This study showed that ingesting LOS can improve body weight gain and fecal 703 
water content, decrease appetite and have no adverse effects on the physiological 704 
status by regulating the gut microbiota, SCFAs and the concentrations of serum 705 
hormones were shown to produce high levels of c-Kit, stem cell factor, and glial cell 706 
line-derived neurotrophic factor and lower expression levels of transient receptor 707 
potential vanilloid 1 and nitric oxide synthase mRNA and protein. These results 708 
indicated that LOS can shorten the time of defecation and promote the intestinal 709 
peristalsis of mice and prevent constipation. 710 
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Figure Caption 893 
Figure 1. Effects of the intake of LOS, FOS, LRS3, or their m xture, for two weeks, 894 
on mice weight (A), food intake (B), and fecal water content (C). 895 
Figure 2. DGGE profiles (A) and quantitative level (B) of bacteria in the intestinal 896 
tract and feces of mice, (C) Structural comparison of gut microbiota at the family 897 
level. 898 
Figure 3. The cluster analysis (A) and the principal component analysis (PCA) (B) 899 
results of the bacteria in the DGGE spectra.  900 
Figure 4. Effects of LOS on the concentration of SCFAs in mouse feces. 901 
Figure 5. Defecating times of the first black feces and the ink propulsion rates in 902 
the small intestine of LOS-treated mice and constipation control mice. 903 
Figure 6. Effect of various samples on serum MLT, Gas, ET, SS AchE, SP and VIP 904 
levels in mice.  905 
Figure 7. Effects of LOS on the mRNA expression of c-Kit, SCF, TRPV1, GDNF 906 
and NOS in the small intestine. 907 
Figure 8. Effects of LOS on the protein expression of c-Kit, SCF, TRPV1, GDNF 908 








Figure 1 915 
Data in the figure represent the mean ± SD of 14 mice in each group. NG: Blank control group; 916 
LG: Low dose of LOS group; MG: Medium dose of LOS group; HG: High dose of LOS group; 917 















Figure 2 931 
 932 
NG: Blank control group; LG: Low dose of LOS group; MG: Medium dose of LOS group; HG: 933 
High dose of LOS group; ORG: Medium dose of both LOS and LRS3 control group; FG: FOS 934 




Figure 3 937 
NG: Blank control group; LG: Low dose of LOS group; MG: Medium dose of LOS group; HG: 938 
High dose of LOS group; ORG: Medium dose of both LOS and LRS3 control group; FG: FOS 939 














Figure 4 952 
 953 
Data in the figure represent the mean ± SD of 14 mice in each group. Different letters in the 954 
same chart represent significant differences between different treatments according to Duncan’s 955 
multiple range test. (p<0.05). NG: Blank control group; LG: Low dose of LOS group; MG: 956 
Medium dose of LOS group; HG: High dose of LOS group; ORG: Medium dose of both LOS 957 











Figure 5 967 
 968 
Data in the figure represent the mean ± SD of 14 mice in each group. Different letters in the 969 
same chart represent significant differences between different treatments according to Duncan’s 970 
multiple range test. (p<0.05). NG: Blank control group; LG: Low dose of LOS group; MG: 971 
Medium dose of LOS group; HG: High dose of LOS group; ORG: Medium dose of both LOS 972 










Figure 6 981 
Data in the figure represent the mean ± SD of 14 mice in each group. Different letters in the 982 
same chart represent significant differences between different treatments according to Duncan’s 983 
multiple range test. (p<0.05). NG: Blank control group; LG: Low dose of LOS group; MG: 984 
Medium dose of LOS group; HG: High dose of LOS group; ORG: Medium dose of both LOS 985 
and LRS3 control group; FG: FOS control group; MOG: Model group. MLT: Motlin; GAS: 986 
Gastrin; ET: Endothelin; SS: Somatostatin; AChE: Acetylcholine enzyme; SP: Substance P; 987 










Figure 7 996 
Data in the figure represent the mean ± SD of 14 mice in each group. Different letters in the 997 
same chart represent significant differences between different treatments according to Duncan’s 998 
multiple range test. (p<0.05). NG: Blank control group; LG: Low dose of LOS group; MG: 999 
Medium dose of LOS group; HG: High dose of LOS group; ORG: Medium dose of both LOS 1000 
and LRS3 control group; FG: FOS control group; MOG：Model group; SCF: Stem cell factor; 1001 
GDNF: Glial cell line-derived neurotrophic factor; TRPV1: Transient receptor potential 1002 










Figure 8 1011 
n = 14 mice in each group. NG: Blank control group; LG: Low dose of LOS group; MG: 1012 
Medium dose of LOS group; HG: High dose of LOS group; ORG: Medium dose of both LOS 1013 
and LRS3 control group; FG: FOS control group; MOG：Model group; SCF: Stem cell factor; 1014 
GDNF: Glial cell line-derived neurotrophic factor; TRPV1: Transient receptor potential 1015 




















Corn Starch 64 Lard 4.85 
Casein 12 Lysine 0.92 
Maltodextrin 4 Methionine 0.62 
Cellulose 3 Sucrose 0.15 
Soy Protein 7 Choline chloride 0.1 
NaCl 0.2 Microelement Premix 0.12 
CaHPO4 1.8 Vitamin Premix 0.04 
CaCO3 1.08   
Microelement Premix: including FeSO4.7H2O, CuSO4.5H2O, MnSO4.H2O, 1028 
ZnSO4.7H2O, Na2SeO3, KI 1029 
Vitamin Premix: including VE, VB1, VB6, VB5, VB11, biotin and other vitamins 1030 
 1031 
Table 2. Alpha diversity analysis in mice by diet 1032 
Diet 
Shannon-Wiener 
Diversity index (H′) 
Evenness(E) Richness(S) 
NG 3.46 0.990 33 
CoG 3.06 0.989 22 
CeG 3.18 0.988 25 
LG 3.14 0.988 24 
MG 3.24 0.994 26 
HG 3.11 0.992 23 
ORG 3.07 0.995 22 
FG 3.16 0.995 24 
NG: Blank control group; LG: Low dose of LOS group; MG: Medium dose of LOS group; HG: 1033 
High dose of LOS group; ORG: Medium dose of both LOS and LRS3 control group; FG: FOS 1034 






































Band 5 Acetatifactor muris NR_117905 99 




















Band 9 Alistipes putredinis NR_113152 99 
Rikenellaceae;            
Alistipes 
Band 10 Alistipes finegoldii NR_102944 90 






































Lachnospiraceae;            
Lachnoanaerobaculum 
Band 17 Roseburia hominis NR_074809 97 
Lachnospiraceae;            
Roseburia 


































Band 24 Clostridium grantii NR_026131 95 














































Lachnospiraceae;            
Marvinbryantia 





 Lotus seed oligosaccharides enhance the proportion of probiotics in gut 
microbiota. 
 The time of defecation is related to the diet of oligosaccharides. 
 The effects of medium and high doses of oligosaccharides are stronger than those 
of low doses. 
 Feeding with oligosaccharide-resistant starch complexes has a better effect on 
beneficial gut microbiota. 
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